7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.9B | -$86M | 0.0% | -4.4% | -$69M | — | $78M |
| 2024 | $1.4B | -$43M | 0.0% | -3.3% | $33M | — | $195M |
| 2023 | $1.3B | -$213M | 20.4% | -16.3% | -$145M | — | $176M |
| 2022 | $1.1B | -$339M | 6.4% | -26.1% | -$208M | $0 | $186M |
| 2021 | $1.5B | -$588M | -5.4% | -43.3% | -$283M | $20M | $300M |
| 2020 | $673M | -$136M | 0.0% | -13.8% | -$119M | $127M | $92M |
| 2019 | $462M | -$364M | 0.0% | -39.6% | -$160M | — | $68M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $749M | $27M | 0.0% | 3.6% | $107M | — | $173M |
| Dec '25 | $488M | — | 0.0% | -10.1% | -$69M | — | $78M |
| Sep '25 | $497M | -$24M | 0.0% | -4.9% | $11M | — | $190M |
| Jun '25 | $478M | -$11M | 0.0% | -2.2% | $5M | — | $189M |
| Mar '25 | $462M | -$1M | 0.0% | -0.3% | -$16M | — | $155M |
| Dec '24 | $337M | — | 0.0% | -6.4% | -$86M | — | $195M |
| Sep '24 | $331M | -$9M | 24.5% | -2.7% | $50M | — | $288M |
| Jun '24 | $356M | $7M | 30.3% | 2.0% | $44M | — | $255M |
| Mar '24 | $347M | -$19M | 23.6% | -6.5% | $25M | — | $208M |
| Dec '23 | $312M | -$70M | 19.9% | -20.2% | -$258M | — | $176M |
| Sep '23 | $306M | -$41M | 23.0% | -11.0% | -$19M | — | $352M |
| Jun '23 | $320M | -$29M | 23.7% | -9.0% | $53M | — | $393M |
| Mar '23 | $322M | -$73M | 14.7% | -24.8% | $79M | — | $273M |
| Dec '22 | $899M | -$84M | 0.6% | -11.9% | -$296M | $0 | $186M |
| Sep '22 | $857M | -$75M | 2.0% | -8.6% | $101M | $20M | $383M |
| Jun '22 | $847M | -$104M | -1.4% | -12.1% | -$39M | $20M | $324M |
| Mar '22 | $874M | -$75M | 1.4% | -10.0% | -$57M | $20M | $274M |
| Dec '21 | $432M | -$187M | -2.3% | -43.2% | -$80M | $20M | $300M |
| Sep '21 | $427M | -$35M | -2.1% | -34.9% | -$45M | $20M | $202M |
| Jun '21 | $412M | -$318M | -11.2% | -44.1% | -$64M | $20M | $486M |
How the market has priced CLOV against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Clover Health Investments, Corp. /De's revenue has grown 23.4% per year. These are computed facts, not advice.
As of FY2025, Clover Health Investments, Corp. /De reported — of total debt against $78M of cash.
In FY2025, gross margin was —, operating margin -4.4%, and net margin -4.4%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.